Peter HH - Search Results

1

Systemic lupus erythematosus and neutropaenia: a hallmark of haematological manifestations.

Meyer A, Guffroy A, Blaison G, Dieudonne Y, Amoura Z, Bonnotte B, Fiehn C, Kieffer P, Lorenz HM, Magy-Bertrand N, Maurier F, Pennaforte JL, Peter HH, Schwarting A, Sibilia J, Arnaud L, Martin T, Voll RE, Korganow AS; LBBR/Rarenet group. Meyer A, et al. Among authors: peter hh. Lupus Sci Med. 2020 Jul;7(1):e000399. doi: 10.1136/lupus-2020-000399. Lupus Sci Med. 2020. PMID: 32616563 Free PMC article.

2

Clinical images: Anetoderma in systemic lupus erythematosus with antiphospholipid antibodies.

Venhoff N, Miehle N, Jüttner E, Peter HH, Walker UA. Venhoff N, et al. Among authors: peter hh. Arthritis Rheum. 2005 Jul;52(7):2228. doi: 10.1002/art.21063. Arthritis Rheum. 2005. PMID: 15986337 Free article. No abstract available.

3

Elevated anticardiolipin antibodies in autoimmune haemolytic anaemia irrespective of underlying systemic lupus erythematosus.

Lang B, Straub RH, Weber S, Röther E, Fleck M, Peter HH. Lang B, et al. Among authors: peter hh. Lupus. 1997;6(8):652-5. doi: 10.1177/096120339700600806. Lupus. 1997. PMID: 9364424

4

The crossroads of autoimmunity and immunodeficiency: Lessons from polygenic traits and monogenic defects.

Grimbacher B, Warnatz K, Yong PFK, Korganow AS, Peter HH. Grimbacher B, et al. Among authors: peter hh. J Allergy Clin Immunol. 2016 Jan;137(1):3-17. doi: 10.1016/j.jaci.2015.11.004. J Allergy Clin Immunol. 2016. PMID: 26768758 Review.

5

Impact of rituximab on immunoglobulin concentrations and B cell numbers after cyclophosphamide treatment in patients with ANCA-associated vasculitides.

Venhoff N, Effelsberg NM, Salzer U, Warnatz K, Peter HH, Lebrecht D, Schlesier M, Voll RE, Thiel J. Venhoff N, et al. Among authors: peter hh. PLoS One. 2012;7(5):e37626. doi: 10.1371/journal.pone.0037626. Epub 2012 May 21. PLoS One. 2012. PMID: 22629432 Free PMC article.

6

B cell homeostasis is disturbed by immunosuppressive therapies in patients with ANCA-associated vasculitides.

Thiel J, Salzer U, Hässler F, Effelsberg NM, Hentze C, Sic H, Bartsch M, Miehle N, Peter HH, Warnatz K, Schlesier M, Voll RE, Venhoff N. Thiel J, et al. Among authors: peter hh. Autoimmunity. 2013 Nov;46(7):429-38. doi: 10.3109/08916934.2013.798652. Epub 2013 Jun 6. Autoimmunity. 2013. PMID: 23742274

7

Complement split product C3d as an indicator of disease activity in systemic lupus erythematosus.

Röther E, Lang B, Coldewey R, Hartung K, Peter HH. Röther E, et al. Among authors: peter hh. Clin Rheumatol. 1993 Mar;12(1):31-5. doi: 10.1007/BF02231555. Clin Rheumatol. 1993. PMID: 8467609

8

Kinetics of hepatitis C (HCV) viraemia and quasispecies during treatment of HCV associated cryoglobulinaemia with pulse cyclophosphamide.

Thiel J, Peters T, Mas Marques A, Rösler B, Peter HH, Weiner SM. Thiel J, et al. Among authors: peter hh. Ann Rheum Dis. 2002 Sep;61(9):838-41. doi: 10.1136/ard.61.9.838. Ann Rheum Dis. 2002. PMID: 12176813 Free PMC article.

9

Alterations of cerebral glucose metabolism indicate progress to severe morphological brain lesions in neuropsychiatric systemic lupus erythematosus.

Weiner SM, Otte A, Schumacher M, Brink I, Juengling FD, Sobanksi T, Nitzsche EU, Peter HH. Weiner SM, et al. Among authors: peter hh. Lupus. 2000;9(5):386-9. doi: 10.1191/096120300678828370. Lupus. 2000. PMID: 10878734

10

Active vaccination in patients with common variable immunodeficiency (CVID).

Goldacker S, Draeger R, Warnatz K, Huzly D, Salzer U, Thiel J, Eibel H, Schlesier M, Peter HH. Goldacker S, et al. Among authors: peter hh. Clin Immunol. 2007 Sep;124(3):294-303. doi: 10.1016/j.clim.2007.04.011. Epub 2007 Jun 29. Clin Immunol. 2007. PMID: 17602874 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

431 results

Search Page